Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 402 followers
Latest posts
Last updated 15 minutes ago
FDA floats possible approach to repurpose approved drugs under new uses
15 minutes ago
The framework would leverage existing safety data on approved drugs to provide...
Sun recalls US chemotherapy batch, citing glass particle contamination concerns
about 1 hour ago
Generics juggernaut Sun Pharma is pulling one lot of a chemotherapy drug...
Bora snaps up MacroGenics’ manufacturing, CDMO operations for up to $127.5M
about 1 hour ago
Taiwan’s Bora Group will shell out up to $127.5 million to acquire...
BeOne's Venclexta challenger Beqalzi nets FDA approval as first BCL-2 for mantle cell lymphoma
about 17 hours ago
BeOne Medicines has entered the BCL-2 arena, securing an FDA green light...
As Trump arrives in China, Big Pharma CEOs are notably absent
about 19 hours ago
As President Trump lands in Beijing, one major industry is missing from...
Haleon tackles sports injuries with latest soccer play
about 20 hours ago
Haleon has completed a hat-trick of recent soccer initiatives, inking a pain...
BeOne Medicines’ Brukinsa TV ad 'Clarity' hit by FDA over 'misleading suggestions'
about 21 hours ago
The FDA has issued an untitled letter to BeOne Medicines’ U.S. subsidiary...
Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
about 22 hours ago
Takeda's multiyear slim-down is expected to hit about 4,500 roles during the...
Merck KGaA looks to M&A to bolster its 'rather slim' pipeline
about 22 hours ago
Under new CEO Kai Beckmann, Merck KGaA is emphasizing M&A to stock...
Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies
about 22 hours ago
Eli Lilly and Novo Nordisk are building cases for their incretin drugs...
Valneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines
1 day ago
Valneva is planning to shrink its headcount by up to 15% as...
BioMarin consolidates staff at Amicus HQ after closing $4.8B deal for rare disease peer
1 day ago
Shortly after locking down its $4.8 billion deal for rare disease compatriot...